These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6398629)

  • 21. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
    Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM
    Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
    Bertino JR; Cashmore AR; Hillcoat BL
    Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
    Hamrell M; Laszlo J; Brown OE; Sedwick WD
    Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
    [No Abstract]   [Full Text] [Related]  

  • 24. Thermodynamic study of the influence of NADPH on the binding of methotrexate and its metabolites to a mammalian dihydrofolate reductase.
    Gilli RM; Sari JC; Sica LM; Briand CM
    Biochim Biophys Acta; 1988 Jan; 964(1):53-60. PubMed ID: 3334873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydrofolic reductase in human blood cells. I. Techniques for the study of enzyme activity and intracellular amethopterin content.
    Martelli MF; Tonato M; Grignani F
    Enzymol Biol Clin (Basel); 1967; 8(5):353-62. PubMed ID: 4383611
    [No Abstract]   [Full Text] [Related]  

  • 26. Techniques for the measurement of methotrexate in biological samples.
    Aherne GW; Quinton M
    Cancer Treat Rep; 1981; 65 Suppl 1():55-60. PubMed ID: 7326665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A soluble dihydrofolate reductase from human placenta: purification and properties.
    Jarabak J; Bachur NR
    Arch Biochem Biophys; 1971 Feb; 142(2):417-25. PubMed ID: 4396284
    [No Abstract]   [Full Text] [Related]  

  • 28. Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites.
    Gourley DG; Schüttelkopf AW; Leonard GA; Luba J; Hardy LW; Beverley SM; Hunter WN
    Nat Struct Biol; 2001 Jun; 8(6):521-5. PubMed ID: 11373620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
    Hicks SN; Smiley RD; Hamilton JB; Howell EE
    Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrofolate reductase from a methotrexate-resistant Escherichia coli.
    Poe M; Greenfield NJ; Williams MN
    J Biol Chem; 1974 May; 249(9):2710-6. PubMed ID: 4151306
    [No Abstract]   [Full Text] [Related]  

  • 32. 131-I-3'-iodoaminopterin: a gamma-labeled active-site-directed enzyme inhibitor.
    Johns DG; Spencer RP; Chang PK; Bertino JR
    J Nucl Med; 1968 Oct; 9(10):530-6. PubMed ID: 5729201
    [No Abstract]   [Full Text] [Related]  

  • 33. Rational automatic search method for stable docking models of protein and ligand.
    Mizutani MY; Tomioka N; Itai A
    J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
    Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
    Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate.
    Tsukamoto T; Kitazume T; McGuire JJ; Coward JK
    J Med Chem; 1996 Jan; 39(1):66-72. PubMed ID: 8568828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
    Ercikan-Abali EA; Waltham MC; Dicker AP; Schweitzer BI; Gritsman H; Banerjee D; Bertino JR
    Mol Pharmacol; 1996 Mar; 49(3):430-7. PubMed ID: 8643082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the administration of methotrexate in antimetabolite therapy.
    Epstein E; Baginski ES; Zac B
    Ann Clin Lab Sci; 1976; 6(4):312-7. PubMed ID: 9024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
    Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
    Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
    Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.